Contrast Media & Molecular Imaging

Contrast Media & Molecular Imaging / 2019 / Article

Erratum | Open Access

Volume 2019 |Article ID 7843735 | https://doi.org/10.1155/2019/7843735

Manuel Scimeca, Nicoletta Urbano, Rita Bonfiglio, Sarah Natalia Mapelli, Carlo Vittorio Catapano, Giuseppina Maria Carbone, Sara Ciuffa, Mario Tavolozza, Orazio Schillaci, Alessandro Mauriello, Elena Bonanno, "Erratum to “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”", Contrast Media & Molecular Imaging, vol. 2019, Article ID 7843735, 1 page, 2019. https://doi.org/10.1155/2019/7843735

Erratum to “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”

Received29 Jan 2019
Accepted04 Feb 2019
Published11 Mar 2019

In the article titled “Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients” [1], the name of the third author was reversed. The corrected authors’ list is shown above.

References

  1. M. Scimeca, N. Urbano, B. Rita et al., “Prostate osteoblast-like cells: a reliable prognostic marker of bone metastasis in prostate cancer patients,” Contrast Media & Molecular Imaging, vol. 2018, Article ID 9840962, 12 pages, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Manuel Scimeca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views385
Downloads270
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.